Biosurgery Market Size, Share, Trends, Growth Outlook

Biosurgery Market is estimated to increase at a Compounded Annual Growth Rate of 7.2% CAGR over the forecast period from 2024 to 2030

The Biosurgery Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Product (Bone Graft Substitutes, Soft-tissue attachments, Hemostatic agents, Surgical sealants and adhesives, Adhesion Barriers, Staple-Line Reinforcement Agents), By Application (Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery, Urological Surgery, Thoracic Surgery, Others).

An Introduction to Biosurgery Market in 2024

Biosurgery refers to surgical procedures and techniques that involve the use of biological materials, such as autologous tissues, allografts, xenografts, or bioactive agents, to promote tissue repair, regeneration, or hemostasis. In 2024, the field of biosurgery continues to expand with advancements in biomaterials science, tissue engineering, and regenerative medicine aimed at enhancing surgical outcomes, reducing complications, and improving patient recovery. From tissue sealants and hemostatic agents to regenerative scaffolds and wound dressings, biosurgery products offer versatile solutions for various surgical specialties, including general surgery, orthopedics, neurosurgery, and plastic surgery. Moreover, with the integration of stem cells, growth factors, and gene therapy approaches, biosurgery techniques enable targeted tissue repair, enhanced wound healing, and functional restoration in challenging clinical scenarios, such as chronic wounds, traumatic injuries, and tissue defects. By harnessing the regenerative capacity of biological materials and the body's innate healing mechanisms, biosurgery facilitates minimally invasive surgical approaches, reduces the need for synthetic implants or foreign materials, and promotes natural tissue repair and remodeling, ultimately improving patient outcomes and quality of life.

Market Trend: Advancements in Minimally Invasive Surgical Techniques

A significant trend in the biosurgery market is the ongoing advancements in minimally invasive surgical techniques. Minimally invasive surgery (MIS) has revolutionized the field of surgery by offering patients less invasive treatment options with reduced recovery times, shorter hospital stays, and lower complication rates compared to traditional open surgeries. Biosurgery products, such as surgical sealants, hemostatic agents, and adhesion barriers, play a critical role in supporting minimally invasive procedures by promoting tissue repair, controlling bleeding, and preventing post-operative complications. With the continuous evolution of surgical technologies and techniques, there is a growing demand for innovative biosurgery solutions that enable surgeons to perform complex procedures with greater precision, safety, and efficiency, driving market growth and adoption of biosurgery products in various surgical specialties.

Market Driver: Rising Incidence of Chronic Conditions and Surgical Procedures

The primary driver fueling the growth of the biosurgery market is the rising incidence of chronic conditions and surgical procedures worldwide. Chronic conditions, such as cardiovascular diseases, cancer, and orthopedic disorders, often require surgical intervention to alleviate symptoms, restore function, or remove diseased tissue. Additionally, an aging population, sedentary lifestyles, and changes in dietary habits contribute to the prevalence of chronic conditions and surgical needs. Biosurgery products are essential in the management of surgical procedures by providing hemostasis, tissue sealing, and wound healing support, helping to reduce surgical complications, improve patient outcomes, and enhance overall surgical experience. As the global burden of chronic diseases continues to increase, the demand for biosurgery products is expected to rise, driving market expansion and innovation in the biosurgery industry.

Market Opportunity: Development of Advanced Tissue Regeneration Solutions

A potential opportunity for the biosurgery market lies in the development of advanced tissue regeneration solutions that promote faster and more efficient tissue repair and regeneration. While traditional biosurgery products focus primarily on hemostasis and tissue sealing, there is growing interest in regenerative medicine approaches that aim to restore damaged or diseased tissues to their original structure and function. Advanced tissue regeneration solutions, such as tissue scaffolds, growth factors, and stem cell therapies, offer promising strategies for promoting tissue repair, accelerating wound healing, and regenerating damaged organs or tissues. By leveraging advancements in biomaterials, tissue engineering, and regenerative medicine technologies, biosurgery companies can develop innovative products that address unmet clinical needs, improve patient outcomes, and unlock new opportunities for growth and differentiation in the biosurgery market. Additionally, collaboration with academic institutions, research organizations, and healthcare providers can facilitate the translation of basic research findings into clinically relevant biosurgery solutions, further expanding the potential impact of advanced tissue regeneration technologies in surgical practice.

Biosurgery Market Share Analysis: Surgical Sealants and Adhesives is the fastest growing segment over the forecast period to 2030

Among the diverse range of products in the Biosurgery Market, surgical sealants and adhesives stand out as the fastest-growing segment. Several factors contribute to this growth trajectory. Firstly, there is a growing preference for these products over traditional methods like sutures and staples due to their superior efficacy in achieving hemostasis and sealing tissues. Additionally, advancements in biotechnology have led to the development of highly effective natural/biological and synthetic sealants and adhesives, further driving their adoption in various surgical procedures. Moreover, the increasing volume of surgeries across different specialties, including orthopedic, cardiovascular, and reconstructive surgery, has fueled the demand for these products. They offer improved patient outcomes, reduced post-operative complications, and enhanced surgical precision. As a result, the surgical sealants and adhesives segment is experiencing rapid growth within the biosurgery market, driven by technological advancements, expanding applications, and the growing preference for minimally invasive surgical techniques.

Biosurgery Competitive Analysis

The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossB. Braun Melsungen AG, Baxter International Inc, Becton, Dickinson & Co., CSL Ltd, Cyrolife Inc, Hemostasis Llc, Integra Lifesciences Holdings Corp, Johnson & Johnson, Kuros Biosciences AG, Medtronic Plc, Orthofix Medical Inc , Pfizer Inc, Smiths & Nephew Plc., Stryker Corp, Zimmer Biomet Holdings Inc

Biosurgery Market Segmentation

By Product
Bone Graft Substitutes
-Demineralized bone matrix
-Synthetic Bone Grafts
-Bone Morphogenetic Proteins
-Others
Soft-tissue attachments
-Synthetic meshes
-Biological meshes
Hemostatic agents
-Thrombin-based hemostatic agents
-Oxidized regenerated cellulose-based hemostatic agents
-Combination hemostatic agents
Surgical sealants and adhesives
-Natural/Biological Sealants and Adhesives
-Synthetic and Semi-Synthetic Sealants and Adhesives
Adhesion Barriers
-Synthetic Adhesion Barriers
-Natural Adhesion Barriers
Staple-Line Reinforcement Agents
By Application
Orthopedic Surgery
General Surgery
Neurological Surgery
Cardiovascular Surgery
Reconstructive Surgery
Gynecological Surgery
Urological Surgery
Thoracic Surgery
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Biosurgery Market Companies

B. Braun Melsungen AG
Baxter International Inc
Becton, Dickinson & Co.
CSL Ltd
Cyrolife Inc
Hemostasis Llc
Integra Lifesciences Holdings Corp
Johnson & Johnson
Kuros Biosciences AG
Medtronic Plc
Orthofix Medical Inc
Pfizer Inc
Smiths & Nephew Plc.
Stryker Corp
Zimmer Biomet Holdings Inc

Reasons to Buy the Biosurgery Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Biosurgery Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Biosurgery Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Biosurgery Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Biosurgery Market Size Outlook, $ Million, 2021 to 2030
3.2 Biosurgery Market Outlook by Type, $ Million, 2021 to 2030
3.3 Biosurgery Market Outlook by Product, $ Million, 2021 to 2030
3.4 Biosurgery Market Outlook by Application, $ Million, 2021 to 2030
3.5 Biosurgery Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Biosurgery Industry
4.2 Key Market Trends in Biosurgery Industry
4.3 Potential Opportunities in Biosurgery Industry
4.4 Key Challenges in Biosurgery Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Biosurgery Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Biosurgery Market Outlook by Segments
7.1 Biosurgery Market Outlook by Segments, $ Million, 2021- 2030
By Product
Bone Graft Substitutes
-Demineralized bone matrix
-Synthetic Bone Grafts
-Bone Morphogenetic Proteins
-Others
Soft-tissue attachments
-Synthetic meshes
-Biological meshes
Hemostatic agents
-Thrombin-based hemostatic agents
-Oxidized regenerated cellulose-based hemostatic agents
-Combination hemostatic agents
Surgical sealants and adhesives
-Natural/Biological Sealants and Adhesives
-Synthetic and Semi-Synthetic Sealants and Adhesives
Adhesion Barriers
-Synthetic Adhesion Barriers
-Natural Adhesion Barriers
Staple-Line Reinforcement Agents
By Application
Orthopedic Surgery
General Surgery
Neurological Surgery
Cardiovascular Surgery
Reconstructive Surgery
Gynecological Surgery
Urological Surgery
Thoracic Surgery
Others

8 North America Biosurgery Market Analysis and Outlook To 2030
8.1 Introduction to North America Biosurgery Markets in 2024
8.2 North America Biosurgery Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Biosurgery Market size Outlook by Segments, 2021-2030
By Product
Bone Graft Substitutes
-Demineralized bone matrix
-Synthetic Bone Grafts
-Bone Morphogenetic Proteins
-Others
Soft-tissue attachments
-Synthetic meshes
-Biological meshes
Hemostatic agents
-Thrombin-based hemostatic agents
-Oxidized regenerated cellulose-based hemostatic agents
-Combination hemostatic agents
Surgical sealants and adhesives
-Natural/Biological Sealants and Adhesives
-Synthetic and Semi-Synthetic Sealants and Adhesives
Adhesion Barriers
-Synthetic Adhesion Barriers
-Natural Adhesion Barriers
Staple-Line Reinforcement Agents
By Application
Orthopedic Surgery
General Surgery
Neurological Surgery
Cardiovascular Surgery
Reconstructive Surgery
Gynecological Surgery
Urological Surgery
Thoracic Surgery
Others

9 Europe Biosurgery Market Analysis and Outlook To 2030
9.1 Introduction to Europe Biosurgery Markets in 2024
9.2 Europe Biosurgery Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Biosurgery Market Size Outlook by Segments, 2021-2030
By Product
Bone Graft Substitutes
-Demineralized bone matrix
-Synthetic Bone Grafts
-Bone Morphogenetic Proteins
-Others
Soft-tissue attachments
-Synthetic meshes
-Biological meshes
Hemostatic agents
-Thrombin-based hemostatic agents
-Oxidized regenerated cellulose-based hemostatic agents
-Combination hemostatic agents
Surgical sealants and adhesives
-Natural/Biological Sealants and Adhesives
-Synthetic and Semi-Synthetic Sealants and Adhesives
Adhesion Barriers
-Synthetic Adhesion Barriers
-Natural Adhesion Barriers
Staple-Line Reinforcement Agents
By Application
Orthopedic Surgery
General Surgery
Neurological Surgery
Cardiovascular Surgery
Reconstructive Surgery
Gynecological Surgery
Urological Surgery
Thoracic Surgery
Others

10 Asia Pacific Biosurgery Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Biosurgery Markets in 2024
10.2 Asia Pacific Biosurgery Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Biosurgery Market size Outlook by Segments, 2021-2030
By Product
Bone Graft Substitutes
-Demineralized bone matrix
-Synthetic Bone Grafts
-Bone Morphogenetic Proteins
-Others
Soft-tissue attachments
-Synthetic meshes
-Biological meshes
Hemostatic agents
-Thrombin-based hemostatic agents
-Oxidized regenerated cellulose-based hemostatic agents
-Combination hemostatic agents
Surgical sealants and adhesives
-Natural/Biological Sealants and Adhesives
-Synthetic and Semi-Synthetic Sealants and Adhesives
Adhesion Barriers
-Synthetic Adhesion Barriers
-Natural Adhesion Barriers
Staple-Line Reinforcement Agents
By Application
Orthopedic Surgery
General Surgery
Neurological Surgery
Cardiovascular Surgery
Reconstructive Surgery
Gynecological Surgery
Urological Surgery
Thoracic Surgery
Others

11 South America Biosurgery Market Analysis and Outlook To 2030
11.1 Introduction to South America Biosurgery Markets in 2024
11.2 South America Biosurgery Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Biosurgery Market size Outlook by Segments, 2021-2030
By Product
Bone Graft Substitutes
-Demineralized bone matrix
-Synthetic Bone Grafts
-Bone Morphogenetic Proteins
-Others
Soft-tissue attachments
-Synthetic meshes
-Biological meshes
Hemostatic agents
-Thrombin-based hemostatic agents
-Oxidized regenerated cellulose-based hemostatic agents
-Combination hemostatic agents
Surgical sealants and adhesives
-Natural/Biological Sealants and Adhesives
-Synthetic and Semi-Synthetic Sealants and Adhesives
Adhesion Barriers
-Synthetic Adhesion Barriers
-Natural Adhesion Barriers
Staple-Line Reinforcement Agents
By Application
Orthopedic Surgery
General Surgery
Neurological Surgery
Cardiovascular Surgery
Reconstructive Surgery
Gynecological Surgery
Urological Surgery
Thoracic Surgery
Others
12 Middle East and Africa Biosurgery Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Biosurgery Markets in 2024
12.2 Middle East and Africa Biosurgery Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Biosurgery Market size Outlook by Segments, 2021-2030
By Product
Bone Graft Substitutes
-Demineralized bone matrix
-Synthetic Bone Grafts
-Bone Morphogenetic Proteins
-Others
Soft-tissue attachments
-Synthetic meshes
-Biological meshes
Hemostatic agents
-Thrombin-based hemostatic agents
-Oxidized regenerated cellulose-based hemostatic agents
-Combination hemostatic agents
Surgical sealants and adhesives
-Natural/Biological Sealants and Adhesives
-Synthetic and Semi-Synthetic Sealants and Adhesives
Adhesion Barriers
-Synthetic Adhesion Barriers
-Natural Adhesion Barriers
Staple-Line Reinforcement Agents
By Application
Orthopedic Surgery
General Surgery
Neurological Surgery
Cardiovascular Surgery
Reconstructive Surgery
Gynecological Surgery
Urological Surgery
Thoracic Surgery
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
B. Braun Melsungen AG
Baxter International Inc
Becton, Dickinson & Co.
CSL Ltd
Cyrolife Inc
Hemostasis Llc
Integra Lifesciences Holdings Corp
Johnson & Johnson
Kuros Biosciences AG
Medtronic Plc
Orthofix Medical Inc
Pfizer Inc
Smiths & Nephew Plc.
Stryker Corp
Zimmer Biomet Holdings Inc

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Product
Bone Graft Substitutes
-Demineralized bone matrix
-Synthetic Bone Grafts
-Bone Morphogenetic Proteins
-Others
Soft-tissue attachments
-Synthetic meshes
-Biological meshes
Hemostatic agents
-Thrombin-based hemostatic agents
-Oxidized regenerated cellulose-based hemostatic agents
-Combination hemostatic agents
Surgical sealants and adhesives
-Natural/Biological Sealants and Adhesives
-Synthetic and Semi-Synthetic Sealants and Adhesives
Adhesion Barriers
-Synthetic Adhesion Barriers
-Natural Adhesion Barriers
Staple-Line Reinforcement Agents
By Application
Orthopedic Surgery
General Surgery
Neurological Surgery
Cardiovascular Surgery
Reconstructive Surgery
Gynecological Surgery
Urological Surgery
Thoracic Surgery
Others
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)